{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:00:43Z","timestamp":1778857243279,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":396,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1111\/jth.15227","type":"journal-article","created":{"date-parts":[[2020,12,28]],"date-time":"2020-12-28T18:50:46Z","timestamp":1609181446000},"page":"719-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3769-9148","authenticated-orcid":false,"given":"Ferdows","family":"Atiq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmee","family":"Wuijster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7749-334X","authenticated-orcid":false,"given":"Moniek P.M.","family":"de Maat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0265-4871","authenticated-orcid":false,"given":"Marieke J.H.A.","family":"Kruip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-1371","authenticated-orcid":false,"given":"Frank W.G.","family":"Leebeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1111\/jth.15227_bb0010","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1111\/jth.15227_bb0015","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"3","key":"10.1111\/jth.15227_bb0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/bjh.16681","article-title":"New developments in von Willebrand disease","volume":"191","author":"Fogarty","year":"2020","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1111\/jth.15227_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1111\/jth.15227_bb0030","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"21","key":"10.1111\/jth.15227_bb0035","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1111\/jth.15227_bb0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood-2018-10-844936","article-title":"How I treat low von Willebrand factor levels","volume":"133","author":"Lavin","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1111\/jth.15227_bb0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1111\/jth.15227_bb0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2009.1.106","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease","volume":"2009","author":"Sadler","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1111\/jth.15227_bb0055","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1111\/jth.15227_bb0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2A and 2M von Willebrand disease: a 2\u2010year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1111\/jth.15227_bb0065","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2007-08-109231","article-title":"Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM\u20101VWD","volume":"111","author":"Castaman","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1111\/jth.15227_bb0070","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1111\/j.1538-7836.2006.02070.x","article-title":"Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study","volume":"4","author":"Castaman","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15227_bb0075","first-page":"7","article-title":"Von Willebrand disease in the United States: perspective from the Zimmerman program. Ann","volume":"3","author":"Flood","year":"2018","journal-title":"Blood"},{"issue":"20","key":"10.1111\/jth.15227_bb0080","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1111\/jth.15227_bb0085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1160\/TH12-04-0244","article-title":"Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease","volume":"108","author":"de Wee","year":"2012","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1111\/jth.15227_bb0090","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ajh.24195","article-title":"Bleeding spectrum in children with moderate or severe von Willebrand disease: relevance of pediatric\u2010specific bleeding","volume":"90","author":"Sanders","year":"2015","journal-title":"Am J Hematol"},{"issue":"Suppl 1","key":"10.1111\/jth.15227_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ijlh.12653","article-title":"Controversies in the diagnosis of type 1 von Willebrand disease","volume":"39","author":"Bowman","year":"2017","journal-title":"Int J Lab Hematol"},{"issue":"13","key":"10.1111\/jth.15227_bb0100","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2020002038","article-title":"Low VWF: insights into pathogenesis, diagnosis, and clinical management","volume":"4","author":"O'Donnell","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"10.1111\/jth.15227_bb0105","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1111\/jth.15227_bb0110","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH\u2010BAT: adult and pediatric data from the merging project","volume":"20","author":"Elbatarny","year":"2014","journal-title":"Haemophilia"},{"issue":"19","key":"10.1111\/jth.15227_bb0115","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"Sanders","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1111\/jth.15227_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028576","article-title":"What is an invasive procedure? A definition to inform study design, evidence synthesis and research tracking","volume":"9","author":"Cousins","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"10.1111\/jth.15227_bb0125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 ACC expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.15227_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12884-015-0473-8","article-title":"Regional differences in severe postpartum hemorrhage: a nationwide comparative study of 1.6 million deliveries","volume":"15","author":"Prick","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1111\/jth.15227_bb0135","first-page":"75","article-title":"Society of Obstetricians and Gynaecologists of Canada. Gynaecological and obstetric management of women with inherited bleeding disorders","volume":"95","author":"Demers","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"10.1111\/jth.15227_bb0140","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1373\/clinchem.2012.199000","article-title":"Collagen binding provides a sensitive screen for variant von Willebrand disease","volume":"59","author":"Flood","year":"2013","journal-title":"Clin Chem"},{"issue":"3","key":"10.1111\/jth.15227_bb0145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/hae.13957","article-title":"Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies","volume":"26","author":"Favaloro","year":"2020","journal-title":"Haemophilia"},{"issue":"26","key":"10.1111\/jth.15227_bb0150","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1182\/blood-2014-02-557264","article-title":"The bleeding score predicts clinical outcomes and replacement therapy in adults with von Willebrand disease","volume":"123","author":"Federici","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1111\/jth.15227_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1067\/mhn.2000.107454","article-title":"Evaluation of posttonsillectomy hemorrhage and risk factors","volume":"123","author":"Wei","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1111\/jth.15227_bb0160","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ahj.2012.11.005","article-title":"Thrombotic and bleeding complications after orthopedic surgery","volume":"165","author":"Oberweis","year":"2013","journal-title":"Am Heart J"},{"issue":"4","key":"10.1111\/jth.15227_bb0165","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1053\/j.jvca.2017.12.024","article-title":"Meta\u2010analysis of the sources of bleeding after adult cardiac surgery","volume":"32","author":"Biancari","year":"2018","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"3","key":"10.1111\/jth.15227_bb0170","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.transproceed.2006.01.047","article-title":"Pathophysiology of bleeding in surgery","volume":"38","author":"Marietta","year":"2006","journal-title":"Transplant Proc"},{"issue":"4 Pt 1","key":"10.1111\/jth.15227_bb0175","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0002-9378(95)91493-5","article-title":"Third stage of labor: analysis of duration and clinical practice","volume":"172","author":"Dombrowski","year":"1995","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1111\/jth.15227_bb0180","first-page":"927","article-title":"Secondary postpartum haemorrhage: incidence, morbidity and current management","volume":"108","author":"Hoveyda","year":"2001","journal-title":"BJOG"},{"issue":"4","key":"10.1111\/jth.15227_bb0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/hae.12635","article-title":"Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey","volume":"21","author":"Stoof","year":"2015","journal-title":"Haemophilia"},{"issue":"6","key":"10.1111\/jth.15227_bb0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2006-949665","article-title":"Women and von Willebrand disease: controversies in diagnosis and management","volume":"32","author":"Kadir","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1111\/jth.15227_bb0195","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","article-title":"Pregnancy in women with von Willebrand's disease or factor XI deficiency","volume":"105","author":"Kadir","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1111\/jth.15227_bb0200","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1160\/TH11-03-0180","article-title":"Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease","volume":"106","author":"De Wee","year":"2011","journal-title":"Thromb Haemost"},{"issue":"14","key":"10.1111\/jth.15227_bb0205","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1182\/bloodadvances.2018017418","article-title":"Significant gynecological bleeding in women with low von Willebrand factor levels","volume":"2","author":"Lavin","year":"2018","journal-title":"Blood Adv"},{"key":"10.1111\/jth.15227_bb0210","doi-asserted-by":"crossref","first-page":"447.e1","DOI":"10.1016\/j.ajog.2020.06.044","article-title":"Pharmacologic intervention for the management of retained placenta: a systematic review and meta\u2010analysis of randomized trials","volume":"223","author":"Patrick","year":"2020","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15227","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15227","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622007024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622007024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:31:26Z","timestamp":1761535886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622007024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1538783622007024"],"URL":"https:\/\/doi.org\/10.1111\/jth.15227","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Journal of Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}